Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 5
1984 1
1985 4
1986 2
1987 1
1988 5
1989 3
1990 6
1991 15
1992 7
1993 9
1994 9
1995 9
1996 13
1997 10
1998 11
1999 8
2000 18
2001 13
2002 11
2003 8
2004 9
2005 20
2006 11
2007 14
2008 18
2009 15
2010 11
2011 28
2012 32
2013 30
2014 18
2015 24
2016 17
2017 14
2018 6
2019 6
2020 4
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

423 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.
Lange P, Halpin DM, O'Donnell DE, MacNee W. Lange P, et al. Among authors: macnee w. Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss(Spec Iss):3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 26937185 Free PMC article. Review.
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Hurst JR, et al. Among authors: macnee w. N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883. N Engl J Med. 2010. PMID: 20843247 Free article.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.
Sakornsakolpat P, Prokopenko D, Lamontagne M, Reeve NF, Guyatt AL, Jackson VE, Shrine N, Qiao D, Bartz TM, Kim DK, Lee MK, Latourelle JC, Li X, Morrow JD, Obeidat M, Wyss AB, Bakke P, Barr RG, Beaty TH, Belinsky SA, Brusselle GG, Crapo JD, de Jong K, DeMeo DL, Fingerlin TE, Gharib SA, Gulsvik A, Hall IP, Hokanson JE, Kim WJ, Lomas DA, London SJ, Meyers DA, O'Connor GT, Rennard SI, Schwartz DA, Sliwinski P, Sparrow D, Strachan DP, Tal-Singer R, Tesfaigzi Y, Vestbo J, Vonk JM, Yim JJ, Zhou X, Bossé Y, Manichaikul A, Lahousse L, Silverman EK, Boezen HM, Wain LV, Tobin MD, Hobbs BD, Cho MH; SpiroMeta Consortium; International COPD Genetics Consortium. Sakornsakolpat P, et al. Nat Genet. 2019 Mar;51(3):494-505. doi: 10.1038/s41588-018-0342-2. Epub 2019 Feb 25. Nat Genet. 2019. PMID: 30804561 Free PMC article.
Response.
Maclay JD, MacNee W. Maclay JD, et al. Among authors: macnee w. Chest. 2013 Sep;144(3):1081-1082. doi: 10.1378/chest.13-1352. Chest. 2013. PMID: 24008965 No abstract available.
Ultrafine particles.
Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. Donaldson K, et al. Among authors: macnee w. Occup Environ Med. 2001 Mar;58(3):211-6, 199. doi: 10.1136/oem.58.3.211. Occup Environ Med. 2001. PMID: 11171936 Free PMC article. Review. No abstract available.
Oxidants and COPD.
MacNee W. MacNee W. Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):627-41. doi: 10.2174/156801005774912815. Curr Drug Targets Inflamm Allergy. 2005. PMID: 17305519 Review.
Cardiovascular disease in COPD: mechanisms.
Maclay JD, MacNee W. Maclay JD, et al. Among authors: macnee w. Chest. 2013 Mar;143(3):798-807. doi: 10.1378/chest.12-0938. Chest. 2013. PMID: 23460157 Review.
423 results